News

The evolving needs of Indian pharma industry encompass advanced skills in areas like biologics, AI, and automation ...
Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to ...
Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today ...
Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug ...
Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...
BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...